Recent Quotes
My Watchlist
Indicators
Local Stocks
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Jaguar Health Inc (NQ: JAGX )

4.260 +0.230 (+5.71%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 19, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 469,613
Open 4.030
Bid (Size) 4.240 (10)
Ask (Size) 4.280 (2)
Prev. Close 4.030
Today's Range 3.960 - 4.260
52wk Range 3.072 - 41.76
Shares Outstanding 171,350,166
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Jaguar Health to Report Phase 3 OnTarget Trial Results for Its Cancer Supportive Care Drug Crofelemer on July 23rd and Hold Investor Webcast that Morning
Via ACCESSWIRE
Issuance of New European & Australian Patents Bolster IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS) and Congenital Diarrheal Disorders (CDDs)
Via ACCESSWIRE

Performance

YTD
-53.04%
-53.04%
1 Month
+8.95%
+8.95%
3 Month
-59.91%
-59.91%
6 Month
-32.45%
-32.45%
1 Year
-86.85%
-86.85%

More News

Read More
Jaguar Health Regains Compliance with Nasdaq's Bid Price Requirement
Via ACCESSWIRE
Jaguar Health Reports Approval of All Proposals at June 2024 Annual Meeting of Stockholders
Via ACCESSWIRE
Jaguar Health to Report Pivotal Phase 3 OnTarget Trial Results for its Cancer Supportive Care Drug Crofelemer on or Before July 23, 2024
Via ACCESSWIRE
Jaguar Health Announces New Employee Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Via ACCESSWIRE
Jaguar Health, Inc. Announces Reverse Stock Split
Via ACCESSWIRE
Nasdaq Stocks Soaring to the Top with Strategic Splits: NVDA, INBS, JAGX, SINT, GWAV
Via AB Newswire
Exposures Product Safety
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Jaguar Health Executes Out-License Deal with Joint Venture Magdalena Biosciences for Botanical Drug Candidate for Schizophrenia
Via ACCESSWIRE
Investigator-Initiated Trial of Jaguar Health’s Crofelemer Yields Positive Results for Functional Diarrhea
Via ACCESSWIRE
What's Going On With Jaguar Health Stock?
Via Benzinga
Jaguar Health to Initiate Commercial Footprint in Cancer Supportive Care at American Society of Clinical Oncology (ASCO) Annual Meeting with Exhibit Booth for FDA-Approved Gelclair Oral Mucositis Product
Via ACCESSWIRE
Dow Falls Over 150 Points; Sohu Posts Q1 Loss
Via Benzinga
Topics Stocks
Exposures US Equities
Why Virios Therapeutics Shares Are Trading Lower By Around 48%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why Jaguar Health Stock Is Tanking
Via Benzinga
Nasdaq Surges 100 Points; Wix.com Shares Jump Following Q1 Results
Via Benzinga
Red Lobster Bankruptcy: What Happened to the Popular Seafood Chain?
Via InvestorPlace
Topics Bankruptcy
Exposures Financial Legal
US Stocks Mixed; Li Auto Shares Plummet After Q1 Results
Via Benzinga
Why Is Jaguar Health (JAGX) Stock Down 40% Today?
Via InvestorPlace
Why Wix.com Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.